Sign in

CIK 0001590750 · Large accelerated filer

Viridian Therapeutics, Inc.\DE

Sign in to watch
Ticker
VRDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
471187261
Phone
617.272.4600
Business address
221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
Former names
MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$348,194
in 1 filing

Net −$348,194. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Tousignant Jennifer −$348K Chief Legal Officer sold 100% of stake

Reading 15 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-06-19 KOCH KEVIN Director Grant or award · Stock Option (right to buy) +12,000 12,000
2019-06-19 Hughes Thomas E. Director Grant or award · Stock Option (right to buy) +12,000 12,000
2019-06-19 Hatfield Jeffrey S. Director Grant or award · Stock Option (right to buy) +12,000 12,000
2019-06-19 Bowden Christopher Director Grant or award · Stock Option (right to buy) +12,000 12,000
2019-04-03 Hughes Thomas E. Director Grant or award · Stock Option (right to buy) +10,106 10,106
2019-02-06 RUBIN PAUL D EVP, Research & Development Grant or award · Stock Option (right to buy) +87,000 87,000
2019-02-06 Levy Adam Scott Chief Business Officer Grant or award · Stock Option (right to buy) +74,000 74,000
2019-02-06 Leverone Jason A. CFO, Treasurer & Secretary Grant or award · Stock Option (right to buy) +75,000 75,000
2019-02-06 Marshall William Stuart President & CEO Grant or award · Stock Option (right to buy) +232,000 232,000
2018-10-11 Hughes Thomas E. Director Purchase +10,000 $4.77 $48K 12,827
2018-08-07 Leverone Jason A. CFO, Treasurer & Secretary Option exercise +29,530 $0.57 $17K 30,737
2018-08-07 Leverone Jason A. CFO, Treasurer & Secretary Option exercise · Stock Option (right to buy) −29,530 0
2018-06-27 TURNER JOSEPH L Director Grant or award · Stock Option (right to buy) +12,000 12,000
2018-06-27 Morris Arlene Director Grant or award · Stock Option (right to buy) +12,000 12,000
2018-06-27 KOCH KEVIN Director Grant or award · Stock Option (right to buy) +12,000 12,000
2018-06-27 Hughes Thomas E. Director Grant or award · Stock Option (right to buy) +12,000 12,000
2018-06-27 Hatfield Jeffrey S. Director Grant or award · Stock Option (right to buy) +12,000 12,000
2018-06-27 Bowden Christopher Director Grant or award · Stock Option (right to buy) +12,000 12,000
2018-06-27 Booth Bruce Director Grant or award · Stock Option (right to buy) +12,000 12,000
2018-02-13 Marshall William Stuart President & CEO Option exercise +115,818 $0.57 $66K 265,646

Page 12 of 16 · 309 trades